194 related articles for article (PubMed ID: 30050528)
1. Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita.
Koga H; Kasprick A; López R; Aulí M; Pont M; Godessart N; Zillikens D; Bieber K; Ludwig RJ; Balagué C
Front Immunol; 2018; 9():1558. PubMed ID: 30050528
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases.
Ghorbanalipoor S; Emtenani S; Parker M; Kamaguchi M; Osterloh C; Pigors M; Gross N; Khil'chenko S; Kasprick A; Patzelt S; Wortmann D; Ibrahim IO; Izumi K; Goletz S; Boch K; Kalies K; Bieber K; Smith P; Schmidt E; Ludwig RJ
Front Immunol; 2022; 13():865241. PubMed ID: 36248903
[TBL] [Abstract][Full Text] [Related]
3. PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita.
Koga H; Recke A; Vidarsson G; Pas HH; Jonkman MF; Hashimoto T; Kasprick A; Ghorbanalipoor S; Tenor H; Zillikens D; Ludwig RJ
J Invest Dermatol; 2016 Nov; 136(11):2211-2220. PubMed ID: 27388992
[TBL] [Abstract][Full Text] [Related]
4. Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita.
Kovacs B; Tillmann J; Freund LC; Nimmerjahn F; Sadik CD; Bieber K; Ludwig RJ; Karsten CM; Köhl J
Front Immunol; 2019; 10():3012. PubMed ID: 31993051
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita.
Gross N; Marketon J; Mousavi S; Kalies K; Ludwig RJ; Bieber K
Front Immunol; 2024; 15():1343299. PubMed ID: 38799441
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
7. Immune mechanism-targeted treatment of experimental epidermolysis bullosa acquisita.
Ludwig R
Expert Rev Clin Immunol; 2015; 11(12):1365-78. PubMed ID: 26471717
[TBL] [Abstract][Full Text] [Related]
8. Model systems duplicating epidermolysis bullosa acquisita: a methodological review.
Ludwig RJ
Autoimmunity; 2012 Feb; 45(1):102-10. PubMed ID: 21923614
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita.
Tukaj S; Hellberg L; Ueck C; Hänsel M; Samavedam U; Zillikens D; Ludwig RJ; Laskay T; Kasperkiewicz M
Exp Dermatol; 2015 Jun; 24(6):471-3. PubMed ID: 25739426
[TBL] [Abstract][Full Text] [Related]
10. Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita.
Zillikens H; Kasprick A; Osterloh C; Gross N; Radziewitz M; Hass C; Hartmann V; Behnen-Härer M; Ernst N; Boch K; Vidarsson G; Visser R; Laskay T; Yu X; Petersen F; Ludwig RJ; Bieber K
Front Med (Lausanne); 2021; 8():713312. PubMed ID: 34557502
[TBL] [Abstract][Full Text] [Related]
11. Epidermolysis bullosa acquisita: what's new?
Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
[TBL] [Abstract][Full Text] [Related]
12. Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice.
Mihai S; Hirose M; Wang Y; Thurman JM; Holers VM; Morgan BP; Köhl J; Zillikens D; Ludwig RJ; Nimmerjahn F
Front Immunol; 2018; 9():535. PubMed ID: 29616034
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of Fc gamma RIV inhibition are mediated by selectively blocking immune complex-induced neutrophil activation in epidermolysis bullosa acquisita.
Haeger SC; Kridin K; Pieper M; Griewahn L; Nimmerjahn F; Zillikens D; König P; Ludwig RJ; Hundt JE
Front Immunol; 2022; 13():938306. PubMed ID: 36311755
[TBL] [Abstract][Full Text] [Related]
14. The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita.
Sadeghi H; Gupta Y; Möller S; Samavedam UK; Behnen M; Kasprick A; Bieber K; Müller S; Kalies K; de Castro Marques A; Recke A; Schmidt E; Zillikens D; Laskay T; Mariani J; Ibrahim SM; Ludwig RJ
J Pathol; 2015 Sep; 237(1):111-22. PubMed ID: 25953430
[TBL] [Abstract][Full Text] [Related]
15. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients.
Woodley DT; Ram R; Doostan A; Bandyopadhyay P; Huang Y; Remington J; Hou Y; Keene DR; Liu Z; Chen M
J Invest Dermatol; 2006 Jun; 126(6):1323-30. PubMed ID: 16543893
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.
Hashimoto T; Ishii N; Ohata C; Furumura M
J Pathol; 2012 Sep; 228(1):1-7. PubMed ID: 22692770
[TBL] [Abstract][Full Text] [Related]
17. Calcitriol Treatment Ameliorates Inflammation and Blistering in Mouse Models of Epidermolysis Bullosa Acquisita.
Tukaj S; Bieber K; Witte M; Ghorbanalipoor S; Schmidt E; Zillikens D; Ludwig RJ; Kasperkiewicz M
J Invest Dermatol; 2018 Feb; 138(2):301-309. PubMed ID: 28942362
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita.
Iwata H; Witte M; Samavedam UK; Gupta Y; Shimizu A; Ishiko A; Schröder T; Seeger K; Dahlke M; Rades D; Zillikens D; Ludwig RJ
J Immunol; 2015 Sep; 195(5):1945-54. PubMed ID: 26202985
[TBL] [Abstract][Full Text] [Related]
19. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
Gammon WR; Inman AO; Wheeler CE
J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
[TBL] [Abstract][Full Text] [Related]
20. Identification of quantitative trait loci in experimental epidermolysis bullosa acquisita.
Ludwig RJ; Müller S; Marques Ad; Recke A; Schmidt E; Zillikens D; Möller S; Ibrahim SM
J Invest Dermatol; 2012 May; 132(5):1409-15. PubMed ID: 22297639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
